GlassScriptPhysician profile
Frank C Chen
NPI 1104010586
$2,222.03
in general payments reported to CMS, 2019-2025
17 companies · $355 in 2025
The $355 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $173 · 2021: $360 · 2022: $400 · 2023: $443 · 2024: $177 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $974.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $288.43 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $264.23 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Novo Nordisk INC | $226.31 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $213.34 | 2021-2023 | Breztri, Farxiga |
| Amarin Pharma, INC. | $211.31 | 2019-2021 | |
| Glaxosmithkline, LLC. | $179.06 | 2020-2023 | Arexvy |
| Gilead Sciences, INC. | $172.50 | 2019 | |
| Amgen INC. | $166.70 | 2022-2025 | Evenity, Repatha, Prolia |
| Viatris Specialty LLC | $122.39 | 2025 | Yupelri |
| Mallinckrodt Hospital Products INC. | $75.27 | 2023 | Acthar |
| Agios Pharmaceuticals, INC. | $66.77 | 2024-2025 | Pyrukynd |
| Dynavax Technologies Corporation | $58.74 | 2022-2024 | Heplisav-B |
| Radius Health, INC. | $49.21 | 2020-2022 | |
| Lilly USA, LLC | $45.15 | 2020-2025 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.30 | 2020-2025 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $22.28 | 2023 | Ztlido |
| E.R. Squibb & Sons, L.L.C. | $20.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.